CLINICAL_TRIALS
trial_result
· 2018-12-14
Clinical Trial Update: Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo [NA]
Summary
A completed clinical trial evaluating adjunctive once-daily topical nepafenac 0.3% vs placebo for cystoid macular edema, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Intuor Technologies, Inc. | Conditions: Cystoid Macular Edema | NA | Status: COMPLETED | Results posted: 2018-12-14